Ads
related to: diffuse large b-cell lymphoma- DLBCL Treatment Option
Visit The Patient Website To Learn
More About DLBCL & Treatment.
- Financial Support
View Financial Assistance Options
& How To Apply For Support.
- Questions For Your Doctor
To Make The Most Of Your Next
Doctor's Visit.
- Safety Information
See Important Safety Information
Including Possible Side Effects.
- DLBCL Treatment Option
Search results
Rutgers Cancer Institute and RWJBarnabas Health Set to Unveil Extensive, New Cancer Research...
FOX 4 Kansas City· 3 days agoClinicians and scientists from Rutgers Cancer Institute and RWJBarnabas Health will lead sessions...
Regeneron (REGN) Announces Positive Data on Oncology Candidate
Zacks via Yahoo Finance· 2 days agoRegeneron's (REGN) REGN7075, in combination with its oncology drug Libtayo, generates anti-tumor...
Rutgers Cancer Institute and RWJBarnabas Health Se | Newswise
Newswise· 3 days agoClinicians and scientists from Rutgers Cancer Institute and RWJBarnabas Health will lead sessions...
9 Analysts Have This To Say About Incyte - Incyte (NASDAQ:INCY)
Benzinga· 3 days agoThe firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes a broad array of oncology and dermatology programs ...
Incyte (NASDAQ:INCY) Coverage Initiated at Deutsche Bank Aktiengesellschaft
ETF DAILY NEWS· 1 day agoEquities research analysts at Deutsche Bank Aktiengesellschaft began coverage on shares of Incyte (NASDAQ:INCY – Get Free Report) in a research note issued to investors on Thursday, MarketBeat ...
2024 Presidential Awards for Outstanding Teaching, Faculty Service Awards, Campbell Scholars, and...
Columbia University News· 5 days agoFrom science to medicine, writing to social sciences, here are the Columbians who received awards...
ASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug...
WFRV 5 Green Bay· 3 days agoAscentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that its ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 5 days agoAustin, TX, USA, May 21, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Non-Small-Cell Lung Cancer Drug Market Size, Trends and Insights By Cancer Type (Non-Small Cell Lung Cancer, Metastatic Lung